Profile data is unavailable for this security.
About the company
Bioretec Oy is a Finland-based medical device manufacturer company focusing on the development of strong, safe and reliable bioresorbable implants for pediatric and adult orthopedics. The Company operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oy’s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Company’s products are used all over the world.
- Revenue in EUR (TTM)3.91m
- Net income in EUR-3.79m
- Incorporated1998
- Employees37.00
- LocationBioretec OyYrittajankulma 5TAMPERE 33710FinlandFIN
- Phone+358 207789500
- Fax+358 33170225
- Websitehttps://bioretec.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Micropos Medical AB (publ) | 152.13k | -2.04m | 28.56m | 9.00 | -- | 12.94 | -- | 187.77 | -0.258 | -0.258 | 0.0149 | 0.1692 | 0.0529 | 0.0999 | 0.7758 | 221,497.50 | -70.97 | -64.24 | -89.99 | -82.27 | 74.48 | 114.76 | -1,340.85 | -767.57 | 4.04 | -- | 0.0146 | -- | 50.23 | 5.94 | -26.57 | -- | -- | -- |
| Boule Diagnostics AB | 49.45m | 2.32m | 34.01m | 233.00 | 14.85 | 0.7954 | 7.20 | 0.6876 | 0.6868 | 0.6868 | 14.79 | 12.82 | 0.7378 | 4.35 | 3.53 | 2,526,443.00 | 3.44 | 1.67 | 4.73 | 2.40 | 43.73 | 43.50 | 4.67 | 2.04 | 1.05 | 4.77 | 0.2638 | 42.24 | 4.24 | 6.13 | 96.24 | -9.45 | -9.74 | -- |
| Karolinska Development AB | 166.29k | 2.89m | 37.39m | 8.00 | 13.07 | 0.3523 | 12.63 | 224.85 | 0.1245 | 0.1245 | 0.0072 | 4.62 | 0.0016 | -- | 1.66 | 242,125.00 | 2.71 | 3.37 | 2.73 | 3.83 | -- | -- | 1,734.95 | 1,466.36 | -- | -- | 0.0023 | 0.00 | -12.43 | -8.10 | 106.11 | -29.31 | -- | -- |
| BrainCool AB (publ) | 2.50m | -4.90m | 39.81m | 22.00 | -- | 3.82 | -- | 15.91 | -0.2848 | -0.2848 | 0.1465 | 0.4792 | 0.2418 | 2.09 | 3.32 | 1,214,417.00 | -47.34 | -47.14 | -56.18 | -70.16 | -50.61 | -149.77 | -195.75 | -391.45 | 0.7253 | -7.34 | 0.00 | -- | 32.06 | 78.35 | -34.34 | -- | -11.63 | -- |
| Modulight Oyj | -100.00bn | -100.00bn | 45.34m | 70.00 | -- | 0.8421 | -- | -- | -- | -- | -- | 1.26 | -- | -- | -- | -- | -- | -8.39 | -- | -9.10 | -- | 114.69 | -- | -56.81 | 6.11 | -- | 0.1004 | -- | -12.48 | -8.20 | -38.69 | -- | 63.60 | -- |
| Bioretec Oy | 3.91m | -3.79m | 54.10m | 37.00 | -- | 6.31 | -- | 13.85 | -0.1984 | -0.1984 | 0.2047 | 0.4213 | 0.5524 | 1.46 | 3.68 | 105,594.60 | -53.58 | -67.11 | -65.75 | -97.60 | 69.85 | 70.97 | -96.98 | -134.05 | 4.86 | -4.02 | 0.0754 | -- | 32.77 | 19.77 | -56.82 | -- | -- | -- |
| Senzime AB (publ) | 3.48m | -11.27m | 57.67m | 52.00 | -- | 2.27 | -- | 16.55 | -1.30 | -1.30 | 0.3902 | 2.95 | 0.1045 | 1.34 | 5.80 | -- | -33.80 | -35.69 | -35.58 | -38.00 | 26.75 | -20.59 | -323.45 | -558.68 | 5.85 | -- | 0.0308 | -- | 154.77 | 61.90 | -1.09 | -- | -3.69 | -- |
| Paxman AB (publ) | 18.04m | 715.14k | 65.29m | 91.00 | 91.79 | 6.20 | 28.23 | 3.62 | 0.4358 | 0.4358 | 11.03 | 6.45 | 1.23 | 2.70 | 7.67 | 2,308,978.00 | 4.89 | -5.08 | 6.65 | -7.76 | 69.68 | 69.38 | 3.96 | -5.07 | 1.67 | 2.71 | 0.1251 | -- | 43.99 | 29.35 | 180.69 | -- | 6.26 | -- |
| Mentice AB | 21.81m | -2.23m | 70.02m | 128.00 | -- | 6.01 | 1,989.38 | 3.21 | -1.01 | -1.01 | 10.03 | 5.30 | 0.8435 | 1.97 | 3.88 | 2,082,557.00 | -8.62 | -7.69 | -17.02 | -13.07 | 87.57 | 83.67 | -10.22 | -10.00 | 0.8586 | -- | 0.0553 | -- | 25.54 | 11.74 | 90.81 | -- | -10.83 | -- |
| OssDsign AB | 9.63m | -11.20m | 74.45m | -- | -- | 3.69 | -- | 7.73 | -1.74 | -1.74 | 1.52 | 2.41 | 0.3408 | 6.54 | 6.19 | -- | -39.65 | -38.80 | -44.90 | -44.72 | 74.58 | 72.29 | -116.35 | -203.05 | 4.15 | -30.39 | 0.0132 | -- | 96.82 | 53.26 | -31.30 | -- | -60.35 | -- |
Data as of May 16 2024. Currency figures normalised to Bioretec Oy's reporting currency: Euro EUR
21.37%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Keskin�inen El�kevakuutusyhti� Ilmarinenas of 31 Jan 2024 | 1.35m | 6.64% |
| Keskin�inen Ty�el�kevakuutusyhti� Eloas of 31 Jan 2024 | 854.62k | 4.20% |
| Sp-Fund Management Co. Ltd.as of 31 Jan 2024 | 545.00k | 2.68% |
| OP Asset Management Ltd.as of 31 Jan 2024 | 445.00k | 2.19% |
| Handelsbanken Fonder ABas of 30 Apr 2024 | 395.00k | 1.94% |
| The Social Insurance Institution of Finland (Invt Port)as of 31 Jan 2024 | 292.77k | 1.44% |
| eQ Varainhoito Oyas of 31 Jan 2024 | 236.45k | 1.16% |
| Danske Bank A/S (Investment Management Finland)as of 27 Mar 2024 | 226.55k | 1.11% |
More ▼
Data from 31 Dec 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
